These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inflammation Disrupts Cognitive Integrity via Plasma Neurofilament Light Chain Coupling Brain Networks in Alzheimer's Disease. Yao W; Zhang X; Zhao H; Xu Y; Bai F; J Alzheimers Dis; 2022; 89(2):505-518. PubMed ID: 35871350 [TBL] [Abstract][Full Text] [Related]
25. Serum neurofilament light levels are predictive of all-cause mortality in late middle-aged individuals. Nguyen AD; Malmstrom TK; Aggarwal G; Miller DK; Vellas B; Morley JE EBioMedicine; 2022 Aug; 82():104146. PubMed ID: 35830835 [TBL] [Abstract][Full Text] [Related]
26. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3. Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998 [TBL] [Abstract][Full Text] [Related]
27. The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease. Xiong YL; Meng T; Luo J; Zhang H Eur Neurol; 2021; 84(1):6-15. PubMed ID: 33477142 [TBL] [Abstract][Full Text] [Related]
28. Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia. Veenhuis SJG; Gupta AS; de Gusmão CM; Thornton J; Margus B; Rothblum-Oviatt C; Otto M; Halbgebauer S; van Os NJH; van de Warrenburg BPC; Verbeek MM; Willemsen MAAP Eur J Paediatr Neurol; 2021 May; 32():93-97. PubMed ID: 33878608 [TBL] [Abstract][Full Text] [Related]
29. Neurofilament light chain plasma levels are associated with area of brain damage in experimental cerebral malaria. Wai CH; Jin J; Cyrklaff M; Genoud C; Funaya C; Sattler J; Maceski A; Meier S; Heiland S; Lanzer M; Frischknecht F; Kuhle J; Bendszus M; Hoffmann A Sci Rep; 2022 Jun; 12(1):10726. PubMed ID: 35750882 [TBL] [Abstract][Full Text] [Related]
30. Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy? Custers ML; Vande Vyver M; Kaltenböck L; Barbé K; Bjerke M; Van Eeckhaut A; Smolders I Epilepsia; 2023 Aug; 64(8):2200-2211. PubMed ID: 37264788 [TBL] [Abstract][Full Text] [Related]
31. Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma. Sveijer M; von Bahr Greenwood T; Jädersten M; Kvedaraite E; Zetterberg H; Blennow K; Lourda M; Gavhed D; Henter JI Br J Haematol; 2022 Aug; 198(4):721-728. PubMed ID: 35582775 [TBL] [Abstract][Full Text] [Related]
32. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027 [TBL] [Abstract][Full Text] [Related]
33. Association of neurofilament light chain with renal function: mechanisms and clinical implications. Tang R; Panizzon MS; Elman JA; Gillespie NA; Hauger RL; Rissman RA; Lyons MJ; Neale MC; Reynolds CA; Franz CE; Kremen WS; Alzheimers Res Ther; 2022 Dec; 14(1):189. PubMed ID: 36527130 [TBL] [Abstract][Full Text] [Related]
34. The role of neurofilament light chain in frontotemporal dementia: a meta-analysis. Karantali E; Kazis D; Chatzikonstantinou S; Petridis F; Mavroudis I Aging Clin Exp Res; 2021 Apr; 33(4):869-881. PubMed ID: 32306372 [TBL] [Abstract][Full Text] [Related]
35. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease. Mattsson N; Andreasson U; Zetterberg H; Blennow K; JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578 [TBL] [Abstract][Full Text] [Related]
36. Serum neurofilament light chain as outcome marker for intensive care unit patients. Fisse AL; Pitarokoili K; Leppert D; Motte J; Pedreiturria X; Kappos L; Gold R; Kuhle J; Yoon MS J Neurol; 2021 Apr; 268(4):1323-1329. PubMed ID: 33098034 [TBL] [Abstract][Full Text] [Related]
37. Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV. Ripamonti E; Edén A; Nilsson S; Sönnerborg A; Zetterberg H; Gisslén M J Intern Med; 2023 Apr; 293(4):445-456. PubMed ID: 36443917 [TBL] [Abstract][Full Text] [Related]
38. Associations between neurofilament light-chain protein, brain structure, and chronic kidney disease. van der Plas E; Lullmann O; Hopkins L; Schultz JL; Nopoulos PC; Harshman LA Pediatr Res; 2022 Jun; 91(7):1735-1740. PubMed ID: 34274959 [TBL] [Abstract][Full Text] [Related]
39. Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood. Andreasson U; Gobom J; Delatour V; Auclair G; Noam Y; Lee S; Wen J; Jeromin A; Arslan B; Maceski A; Willemse E; Zetterberg H; Kuhle J; Blennow K Clin Chem Lab Med; 2023 Jun; 61(7):1245-1254. PubMed ID: 36709509 [TBL] [Abstract][Full Text] [Related]
40. Plasma neurofilament light chain concentrations are elevated in youth-onset type 2 diabetes and associated with neuropathy. Fridman V; Sillau S; Ritchie A; Bockhorst J; Coughlan C; Araya P; Espinosa JM; Smith K; Lange EM; Lange LA; Ghormli LE; Drews KL; Zeitler P; Reusch JEB J Peripher Nerv Syst; 2023 Sep; 28(3):460-470. PubMed ID: 37341347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]